2-BUtoxytetrahydro-2H-pyran, 95%, 250mg

4-Methoxy-N-(p-tolyl)aniline, 95.0%, 25g

(2-Chloro-3-methoxypyridin-4-yl)methanol, 98%, 1g

(S)-2-(1,4-Dibenzylpiperazin-2-yl)acetonitrile, 97%, 100mg

1,2,3,4-tetrahydro-4-isoquinolinol hydrochloride, 95.0%, 1g

1-Phenyl-pyrazolidine-3,5-dione, 95%, 1g

N-Boc-PEG5-bromide, 5g

2-[2-(3-Chlorophenoxy)phenyl]acetic acid, 250mg

4-(3-Fluoro-4-methylphenyl)-4-oxobutyric acid, 97.0%, 1g

1-Chloradamantan, min. 98 %, zur Synthese, 100 g, Glasverpackung

3-Chloro-6-(4'-fluorobenzyloxy)benzaldehyde, 95.0%, 5g

({1-[(4-methyl-1-piperazinyl)methyl]cyclopropyl}methyl)amine, 95.0%, 250mg

Imidazol, min. 99 %, 500 g, kunststoffverpackung.